Hans Clevers

Dutch geneticist, immunologist · Netherlands · On the map · Academics · Born 1957 · age 69

Johannes (Hans) Carolus Clevers is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022.

Hans Clevers is read about 31 times a day, in 11 languages.

A typical day, 30 days to 15 June 2026

The middle day of the days counted, so one week of news cannot move it. The line under it is the last 60 days, one point a day.

Something wrong?

Compare Claim

A life in dates

2019Clarivate Citation LaureatesAwardForeign Member of the Royal SocietyAwardKeio Medical Science PrizeAward2016Körber European Science PrizeAwardSwammerdam MedalAward2013Breakthrough Prize in Life SciencesAward2012Dr A.H. Heineken Prize for MedicineAward2011Ernst Jung Prize for MedicineAwardLeopold Griffuel PrizeAward2008Meyenburg PrizeAward2004Louis-Jeantet Prize for MedicineAward2001Spinoza PrizeAward1957Born27 March 1957

Also in Deutsch

Media & music

Photos 1

Awards

Foreign Member of the Royal Society2019

Keio Medical Science Prize2019

Clarivate Citation Laureates2019

Körber European Science Prize2016

Swammerdam Medal2016

Breakthrough Prize in Life Sciences2013

Dr A.H. Heineken Prize for Medicine2012

Ernst Jung Prize for Medicine2011

Leopold Griffuel Prize2011

Meyenburg Prize2008

Louis-Jeantet Prize for Medicine2004

Spinoza Prize2001

Pour le Mérite for Sciences and Arts order

Fellow of the American Academy of Arts and Sciences

About this person

Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research and at the Princess Máxima Center; he remained as an advisor and guest scientist or visiting researcher to both groups. He is also a Professor in Molecular Genetics at Utrecht University.

Country

Netherlands